Clinical Trials of Mavacamten in oHCM
Milind Desai, MD, MBA, and Michelle M. Kittleson, MD, PhD, review the clinical trial data of mavacamten, the first FDA-approved cardiac myosin inhibitor for the treatment of oHCM.
Stay updated with breaking news from Class Ii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Milind Desai, MD, MBA, and Michelle M. Kittleson, MD, PhD, review the clinical trial data of mavacamten, the first FDA-approved cardiac myosin inhibitor for the treatment of oHCM.
San Antonio residents make up 75% of clients at tribe's Lucky Eagle Casino in Eagle Pass.
OMAHA, Neb., Dec. 22, 2022 (GLOBE NEWSWIRE) -- VKGS LLC ("Video King") is pleased to announce today the completion of two additional Managed Services...
OMAHA, Neb., Sept. 23, 2022 (GLOBE NEWSWIRE) -- VKGS LLC ("Video King") is pleased to announce today the completion of its first Managed Services...
DEMING, N.M. (AP) — A legal representative of the Fort Sill Apache tribe seemed...